Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics.

Devlin AM, Ngai YF, Ronsley R, Panagiotopoulos C.

Transl Psychiatry. 2012 Jan 24;2:e71. doi: 10.1038/tp.2011.68.

2.
3.

Associations of MTHFR C677T and MTRR A66G gene polymorphisms with metabolic syndrome: a case-control study in Northern China.

Yang B, Fan S, Zhi X, Wang D, Li Y, Wang Y, Wang Y, Wei J, Zheng Q, Sun G.

Int J Mol Sci. 2014 Nov 25;15(12):21687-702. doi: 10.3390/ijms151221687.

4.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. French.

PMID:
20620267
6.

Initial screening of children treated with second-generation antipsychotics points to an association between physical activity and insulin resistance.

Cote AT, Devlin AM, Panagiotopoulos C.

Pediatr Exerc Sci. 2014 Nov;26(4):455-62. doi: 10.1123/pes.2014-0076.

PMID:
25372380
7.

MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study.

van Winkel R, Moons T, Peerbooms O, Rutten B, Peuskens J, Claes S, van Os J, De Hert M.

Int Clin Psychopharmacol. 2010 Sep;25(5):270-6. doi: 10.1097/YIC.0b013e32833bc60d.

PMID:
20523222
8.

Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.

Morrato EH, Cuffel B, Newcomer JW, Lombardo I, Kamat S, Barron J.

J Clin Psychopharmacol. 2009 Feb;29(1):26-32. doi: 10.1097/JCP.0b013e31819294cb.

PMID:
19142103
9.

Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications.

Panagiotopoulos C, Ronsley R, Davidson J.

Can J Psychiatry. 2009 Nov;54(11):743-9.

PMID:
19961662
10.
11.

High plasma homocysteine increases risk of metabolic syndrome in 6 to 8 year old children in rural Nepal.

Yakub M, Schulze KJ, Khatry SK, Stewart CP, Christian P, West KP.

Nutrients. 2014 Apr 21;6(4):1649-61. doi: 10.3390/nu6041649.

13.

Interaction between the Val158Met catechol-O-methyltransferase gene variant and second-generation antipsychotic treatment on blood pressure in children.

Cote AT, Panagiotopoulos C, Devlin AM.

Pharmacogenomics J. 2015 Feb;15(1):95-100. doi: 10.1038/tpj.2014.35.

PMID:
25048416
16.

Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.

Correll CU, Frederickson AM, Kane JM, Manu P.

J Clin Psychiatry. 2006 Apr;67(4):575-83.

PMID:
16669722
17.

The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.

Koch HG, Nabel P, Junker R, Auberger K, Schobess R, Homberger A, Linnebank M, Nowak-Göttl U.

Eur J Pediatr. 1999 Dec;158 Suppl 3:S113-6.

PMID:
10650848
18.

Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics.

Ellingrod VL, Taylor SF, Dalack G, Grove TB, Bly MJ, Brook RD, Zöllner SK, Pop-Busui R.

J Clin Psychopharmacol. 2012 Apr;32(2):261-5. doi: 10.1097/JCP.0b013e3182485888.

19.
20.

Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.

Safarinejad MR, Shafiei N, Safarinejad S.

Med Oncol. 2011 Dec;28 Suppl 1:S398-412. doi: 10.1007/s12032-010-9723-9.

PMID:
21046286
Items per page

Supplemental Content

Support Center